Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
33.13
-0.51 (-1.52%)
Nov 5, 2024, 11:14 AM EST - Market open
Castle Biosciences Employees
Castle Biosciences had 610 employees as of December 31, 2023. The number of employees increased by 67 or 12.34% compared to the previous year.
Employees
610
Change (1Y)
67
Growth (1Y)
12.34%
Revenue / Employee
$511,275
Profits / Employee
$9,959
Market Cap
918.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Phibro Animal Health | 1,940 |
Autolus Therapeutics | 471 |
Zymeworks | 278 |
Liquidia | 145 |
CARGO Therapeutics | 116 |
Cullinan Therapeutics | 85 |
Pulse Biosciences | 56 |
CSTL News
- 15 hours ago - Castle Biosciences, Inc. (CSTL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 19 hours ago - Castle Biosciences Reports Third Quarter 2024 Results - Business Wire
- 6 days ago - Castle Biosciences Presents Award-Winning Abstract at ACG 2024 Demonstrating Ability of Its TissueCypher® Test to Significantly Reduce Healthcare Costs Associated with the Management of Barrett's Esophagus Patients - Business Wire
- 8 days ago - Castle Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 16 days ago - Castle Biosciences Presents New Data at ASDS from Prospective, Multicenter CONNECTION Study Supporting Use of DecisionDx®-Melanoma to Guide SLNB Decisions in T1a Tumors with High-Risk Features and T1b Tumors - Business Wire
- 20 days ago - Recent Publications Affirm the Value of Gene Expression Profile Testing in Guiding a Definitive Diagnosis and Clinical Decision-Making in Melanocytic Lesions of Uncertain Malignant Potential - Business Wire
- 22 days ago - Castle Biosciences to Release Third Quarter 2024 Financial Results and Host Conference Call on Monday, Nov. 4, 2024 - Business Wire
- 25 days ago - Castle Biosciences to Support the 71st Annual Montagna Symposium on the Biology of the Skin - Business Wire